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Background: Body mass index (BMI) and hemoglobin (Hb) are positively associated with hypertensive disorders
among pregnant women. The aim of this study was to estimate a potential interaction between high BMI and high
Hb concentrations on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in pregnancy.
Methods: We recruited 4497 single-birth women aged 18–43 years who received routine antenatal care at three
hospitals of Guigang, Guangxi, China, from December 2007 to January 2011. Of 4497 participants, 3472 women
were in the first trimester, with following up, 2986 women and 2261 women were left in the second and third
trimester, respectively. Clinical data were derived from medical records of each woman. We used multivariable
linear regression, by trimesters of pregnancy, to evaluate the associations of high BMI and high Hb concentrations
with SBP and DBP according to cross-sectional design.
Results: In multivariable analyses, BMI was positively associated with SBP throughout all trimesters, but the
corresponding association for Hb concentrations only in the first trimester, whereas both BMI and Hb concentrations
were positively associated with DBP in the first and third trimesters. After full adjustment for confounding, the average
differences in SBP and DBP comparing women with high BMI and high Hb to those with non-high BMI and non-high
Hb were 2.9 mmHg (95% CI: 0.8 to 5.0 mmHg) and 3.9 mmHg (95% CI: 1.5 to 6.3 mmHg) in the first trimester, 2.6 mmHg
(95% CI: 0.4 to 4.8 mmHg) and 1.5 mmHg (95% CI: −1.3 to 4.3 mmHg) in the second trimester, and 4.8 mmHg (95% CI:
2.3 to 7.4 mmHg) and 5.7 mmHg (95% CI: 3.2 to 8.3 mmHg) in the third trimester, respectively. With respect to the
interaction, significant combined effects between high BMI and high Hb were confirmed on SBP (P = 0.02) and DBP
(P = 0.004) in the third trimester, and the amount of interaction on SBP and DBP were 2.0 mmHg (95% CI: 0.1 to
3.9 mmHg) and 2.3 mmHg (95% CI: 0.4 to 4.3 mmHg), respectively.
Conclusion: Our findings suggest that high BMI and high Hb concentrations may have a synergistic effect on blood
pressure in late stage of pregnancy.
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High blood pressure during pregnancy contributes to the
risks of not only adverse neonatal outcomes but also
maternal deaths [1,2]. Although the etiology of hyper-
tensive disorders during pregnancy is not yet completely
clear, maternal anthropometric measure such as high body
mass index (BMI) in pregnancy has been reported to* Correspondence: xqqiu9999@sina.com
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reproduction in any medium, provided the orincrease the risk of pregnancy-induced hypertension (PIH)
or preeclampsia [3-6]. Similarly, several studies have shown
that maternal hemoglobin (Hb) levels were positively
associated with PIH [7-9]. Moreover, a review suggests
that higher than normal hemoglobin concentrations should
be regarded as an indicator of possible pregnancy complica-
tions [10]. Some of the above findings [4,5,7], however, may
be limited because of small sample size or insufficient
gestational weeks.
The mechanisms underlying the positive association of
Hb levels with pregnancy blood pressure are incompletelyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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Hb levels might impact hypertensive disorders in pregnant
[7,10,11] as well as non-pregnant women [12] via hemo-
concentration or increased blood viscosity, which is gener-
ally associated with both overall adiposity and abdominal
adiposity [13]. Further, a population-based study, particu-
larly on the association between Hb levels and BMI during
pregnancy, showed that Hb levels were significantly associ-
ated with BMI in 561 pregnant women [14]. However,
less is known about the combined effect of BMI and
Hb levels on blood pressure in pregnancy. Thus, in this
large sample study, we further evaluated the potential
interaction between high BMI and high Hb concentra-
tions on systolic blood pressure (SBP) and diastolic
blood pressure (DBP) in all trimesters of pregnancy.
Methods
Study population
First, we categorized all hospitals that can provide a rou-
tine antenatal care into three stratifications including
primary, secondary, and tertiary hospitals in Guigang,
Guangxi Zhuang Autonomous Region, China, then ran-
domly selected one hospital from each stratification using
cluster sampling. The present study was embedded in
the antenatal care at three hospitals during December
2007 to January 2011. A total of 5701 healthy women
aged ≥18 years with singleton pregnancies who attended
their the first antenatal care at gestational weeks 10 to 16
were accumulatively enrolled, we excluded 41 in vitro
fertilization and 1163 with incomplete data. Finally, 4497
eligible women aged 18–43 years were left to follow up
with the routine antenatal visits. Gestational age was
based on the first day of the last menstrual period, for
1169 women (26%) with neither a known first day of the
last menstrual period nor a regular menstrual cycle, the
ultrasound estimate was used at the first antenatal visit.
Pregnancy was classified into the first, second, and third
trimesters using gestational age: <14, 14–27, and 28–42
weeks, respectively.
The follow-up of study participants throughout preg-
nancy is shown in Figure 1. Of 4497 participants at study
entry, 3472 women were in the first trimester, 1025
women were in the second trimester. With following
up, 2986 women and 2261 women were left at the end
of gestational weeks 24 and 36, respectively. All eligible
participants provided written informed consent, the
Guangxi Medical University Institutional Review Board
approved the present protocols.
Data collection and laboratory measures
The three hospitals performed the same antenatal exam-
ination, laboratory procedure, and quality control. At the
first antenatal visit, baseline information on maternal age,
ethnicity, education, family income, residence, gestationalage, parity, and folic acid supplement was based on inter-
view questionnaires, anthropometric measures (e.g. body
weight and height) and blood pressure were recorded
through physical examinations. Blood pressure readings
and body weight were prospectively recorded from the
first to the last antenatal visit. Blood pressure was mea-
sured with Omron HEM 907 IntelliSense professional
digital blood pressure monitor (Omron Healthcare Ltd.,
Dalian, China) using an averaging mode in a sitting pos-
ition. After at least 5 minutes of rest, an appropriately
sized upper arm cuff was applied to the right arm, the
mean value of two blood pressure readings with a pause
of 60 seconds between each measurement was recorded.
Fasting blood was repeatedly collected at the first ante-
natal visit that ranged from gestational weeks 10 to 16,
around gestational weeks 20, 24, 32, and 36. All samples
were performed using the standard protocol for clinical
laboratory tests. Hb concentration value in whole blood
was performed with Beckman Coulter AcT 5 Diff hema-
tology analyzer (Beckman Coulter Inc., Fullerton, USA),
and was determined via cyanmethhemoglobin method.
The interassay coefficients of variation for Hb concentra-
tions ranged from 3.1% to 8.9% throughout the study
period. Serum total cholesterol, serum triglycerides, and
plasma glucose were measured using Hitachi 7170A or
7020 full-automatic biochemical analyzer (Hitachi Ltd.,
Tokyo, Japan).
Definitions of variables
BMI was calculated by dividing weight in kilograms by
standing height that was measured at enrollment in
meters squared (kg/m2). High BMI was defined as being
more than or equal to the 90th percentile cutoff of
BMI. High Hb concentration was defined as an Hb level
of ≥13.0 g/dL [15]. Family income was the total combined
family income including wages, salaries, self-employment,
and the other source during the last 12 months. Urban
residence was defined as urban districts, central or fringe
areas of city or town with a population density higher
than 1500/km2. Parity was the numbers of times
woman has given birth including stillbirths. Folic acid
supplement was defined as women took a daily supple-
ment of folic acid during 3 months before pregnancy
to the first antenatal visit. Diabetes mellitus was de-
fined as a fasting glucose ≥126 mg/dL, a non-fasting
glucose ≥200 mg/dL, or a self-report physician diagnosis,
or current medication use.
Statistical analysis
With respect to the statistical analyses of BMI, Hb
concentrations, SBP, and DBP, the first measurements at
study entry (gestational weeks 10 to <14) were used for
the first trimester; the averages of measurements including
the first antenatal visit at gestational weeks 14 to 16,
Figure 1 Flow diagram of study participants throughout pregnancy. 3472, 2986, and 2261 at each time point represent the number of women
with complete data including body mass index (BMI), blood pressure, and blood samples as well as basic characteristics in the first, second and third
trimesters, respectively.
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second trimester; the averages of measurements around
gestational weeks 32 and 36 were used for the third
trimester. All analyses were performed using Stata, version
12 (StataCorp LP, College Station, Texas).
We fully evaluated the effects of high BMI and high
Hb concentrations on blood pressure by trimesters of
pregnancy. To do this, first, we generated two binary
variables including bmi (dichotomized into high BMI
and non-high BMI) and hb (dichotomized into high Hb
and non-high Hb), and used multivariable linear regression
to calculate the differences in SBP and DBP comparing
high BMI or high Hb to the non-high category, respect-
ively. Second, we used multivariable linear regression to
evaluate the differences in SBP and DBP, comparing the
combined categories of high BMI and high Hb, high
BMI and non-high Hb, non-high BMI and high Hb tonon-high BMI and non-high Hb, respectively. Third,
using multivariable linear regression, we further assessed
the interaction as departure from additivity between high
BMI and high Hb on SBP and DBP by including bmi, hb,
and the product of bmi and hb in models, and obtained
the amount of interaction, which equaled the regression
coefficient of the product term. The corresponding meth-
odology was described by Knol et al. [16].
For multivariable regression, we fitted 3 models with
progressive levels of adjustment. Model 1 was adjusted for
age (continuous) and ethnicity (Han, Zhuang, other). Model
2 was further adjusted for education (<12 years, ≥12 years),
family income <US$ 3000 (yes, no), urban residence (yes,
no), parity (0, 1, >1), and folic acid supplement (yes, no).
Model 3 was further adjusted for serum total cholesterol
(continuous), serum triglycerides (continuous), and diabetes
mellitus (yes, no).
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The main characteristics of the study population by tri-
mester are shown in Table 1. On average, the mean age
of women by trimester ranged from 25.2 to 26.3 years.
The means of BMI, Hb concentrations, SBP and DBP
by trimester ranged from 22.9 to 26.5 kg/m2, 11.7 to
12.5 g/dL, 107.0 to 112.8 mmHg and 66.4 to 73.8 mmHg,
respectively. BMI increased progressively during preg-
nancy, however, Hb concentrations, SBP and DBP in the
second trimester were lower than in the first and third
trimesters.
In the first trimester, either of BMI and Hb was positively
associated with both SBP and DBP (P <0.05) (Figure 2).
In models adjusted for age and ethnicity, women with
high BMI and high Hb had significantly increased dif-
ferences for SBP and DBP compared to women with
non-high BMI and non-high Hb. After full adjustment,
however, the differences became weak, the average
difference in women with high BMI and high Hb com-
pared to women with non-high BMI and non-high Hb
were 2.9 mmHg (95% CI: 0.8 to 5.0 mmHg) in SBP, and
3.9 mmHg (95% CI: 1.5 to 6.3 mmHg) in DBP, respectively
(Table 2). We found no evidence of significant interaction
between high BMI and high Hb on SBP (P = 0.14) and
DBP (P = 0.38) in full-adjusted models (Table 3).
Only BMI was positively associated with SBP in the
second trimester (P <0.05) (Figure 2). We further found
significant differences in SBP comparing women with
high BMI and high Hb to those with non-high BMI and
non-high Hb, but non-significant in DBP regardless of
multivariable-adjusted models. After full adjustment, the
average differences in SBP and DBP, comparing women
with high BMI and high Hb to those with non-high BMI
and non-high Hb, were 2.6 mmHg (95% CI: 0.4 toTable 1 Baseline characteristics of the study population by tr
Characteristic 1st trimester (N = 3472)
Maternal age, year 26.0 (0.8)
The Han, n (%) 2226 (64.1)
Education (≥12 years), n (%) 1476 (42.5)
Family income (<$ 3000), n (%) 736 (21.2)
Urban residence, n (%) 1628 (46.9)
Parity (nulliparous), n (%) 2170 (62.5)
Folic acid supplement, n (%) 1430 (41.2)
Serum total cholesterol, mg/dL 181.6 (1.1)
Serum triglyceride, mg/dL 124.9 (0.9)
Diabetes mellitus, n (%) 69 (2.0)
Body mass index, kg/m2 22.9 (0.2)
Hemoglobin, g/dL 12.5 (0.2)
Systolic blood pressure, mmHg 110.5 (1.3)
Diastolic blood pressure, mmHg 68.4 (0.6)
†Values are means (standard error) or number (percentage) unless otherwise noted4.8 mmHg) and 1.5 mmHg (95% CI: −1.3 to 4.3 mmHg),
respectively (Table 4). Also, there was no evidence of
significant interaction between high BMI and high Hb
on SBP (P = 0.3) or DBP (P = 0.11) in full-adjusted model
(Table 3).
In the third trimester, BMI was positively with both
SBP and DBP, but higher Hb was only associated with
higher DBP (P <0.05) (Figure 2). After adjustment for
age and ethnicity, there were significant increases in the
differences for SBP and DBP compared to women with
non-high BMI and non-high Hb. Full adjustment for
confounding did not materially affect this association,
the average differences in SBP and DBP, comparing
women with high BMI and high Hb to those with non-
high BMI and non-high Hb, were 4.8 mmHg (95% CI: 2.3
to 7.4 mmHg) and 5.7 mmHg (95% CI: 3.2 to 8.3 mmHg),
respectively (Table 5). For the interaction, we found sig-
nificant synergistic effects between high BMI and high Hb
on SBP (P = 0.02) and DBP (P = 0.004) in full-adjusted
models, the amount of interaction on SBP and DBP were
2.0 mmHg (95% CI: 0.1 to 3.9 mmHg) and 2.3 mmHg
(95% CI: 0.4 to 4.3 mmHg), respectively (Table 3).
Discussion
In this study, differences in the associations of BMI and
Hb with either SBP or DBP were present throughout
pregnancy. BMI was positively associated with SBP across
3 trimesters, but with DBP in the first and third trimesters;
higher Hb concentrations were associated with increased
SBP only in the first trimester, but with increased DBP
in the first and third trimesters. Furthermore, we
found significant interaction between high BMI and
high Hb on elevated both SBP and DBP only in the
third trimester.imesters of pregnancy†
2nd trimester (N = 2986) 3rd trimester (N = 2261)
26.3 (0.5) 25.2 (0.6)
1965 (65.8) 1526 (67.5)
1170 (39.2) 1011 (44.7)
582 (19.5) 355 (15.7)
1582 (53.0) 1302 (57.6)
1765 (59.1) 1490 (65.9)
1135 (38.0) 988 (43.7)
221.5 (0.7) 243.6 (0.8)
177.1 (1.1) 256.8 (1.3)
66 (2.2) 133 (5.9)
24.1 (0.2) 26.5 (0.3)
11.7 (0.1) 11.8 (0.1)
107.0 (1.1) 112.8 (1.0)
66.4 (0.5) 73.8 (0.7)
.
Figure 2 Differences (95% CIs) in SBP and DBP with BMI and Hb by trimesters of pregnancy. Differences were adjusted for age (continuous),
ethnicity (Han, Zhuang, other), education (<12 years, ≥12 years), family income <US$ 3000 (yes, no), urban residence (yes, no), parity (0, 1, >1), folic acid
supplement (yes, no), total cholesterol (continuous), triglycerides (continuous), and diabetes mellitus (yes, no). Comparing the high to the non-high
categories: * P <0.05, ** P <0.001.
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positive association between maternal BMI and blood
pressure, whether in pregnancy [3-6] or prepregnancy
[17-20], although these associations were concluded by
different statistical models. A recent system review includ-
ing 13 trials, however, indicates that dietary intervention
appears effective to reduce total and weekly gestational
weight gain, but no significant effect on preventing pre-
eclampsia and gestational diabetes [21]. For Hb, several
observational studies found significantly increased Hb
concentrations in women who developed PIH in the sec-
ond or third trimester [7-9]. Also, a recent study showedTable 2 Difference (95% CI) in blood pressure by categories o
Non-high BMI (<26.8 kg/m2)
Hb <13.0 g/dL Hb ≥13.0
Number 2218 907
SBP (mmHg)a 109.7 111.7
Model 1b 0.0 (reference) 2.6 (0.9,
Model 2c 0.0 (reference) 2.5 (0.8,
Model 3d 0.0 (reference) 1.4 (−0.3,
DBP (mmHg)a 67.5 69.0
Model 1b 0.0 (reference) 1.9 (−0.3,
Model 2c 0.0 (reference) 1.9 (−0.2,
Model 3d 0.0 (reference) 1.0 (−1.0,
CI, confidence interval; SBP, systolic blood pressure; DBP, diastolic blood pressure; H
aMean SBP; mean DBP.
bModel 1: Adjusted for age (continuous) and ethnicity (Han, Zhuang, other).
cModel 2: Further adjusted for education (<12 years, ≥12 years), family income < US
supplement (yes, no).
dModel 3: Further adjusted for total cholesterol (continuous), triglycerides (continuothat Hb level was positively associated with both SBP and
DBP in a large cohort of healthy individuals [22]. In our
analysis, we excluded women with PIH or preeclampsia
mainly owing to antihypertensive medication, in contrast
to previous research that defined outcome as PIH or pre-
eclampsia, our study thus focused on the physiological
effects of BMI and Hb on blood pressure in the whole
range of trimesters of pregnancy. As a whole, our finding
regarding the positive associations of BMI and Hb with
blood pressure supports previous research.
The mechanisms for increased BMI or Hb concentra-
tions with elevated blood pressure in pregnancy have beenf BMI and Hb levels in first trimester
High BMI (≥26.8 kg/m2)
g/dL Hb <13.0 g/dL Hb ≥13.0 g/dL
213 134
112.4 113.3
4.2) 3.0 (0.5, 5.5) 4.0 (2.1, 6.0)
4.2) 2.9 (0.5, 5.3) 3.8 (1.7, 5.4)
3.1) 2.6 (0.3, 4.9) 2.9 (0.8, 5.0)
70.0 72.4
4.2) 3.2 (0.6, 5.7) 5.1 (2.7, 7.6)
4.1) 3.2 (0.8, 5.6) 5.0 (2.7, 7.4)
3.0) 2.5 (0.1, 4.9) 3.9 (1.5, 6.3)
b, Hemoglobin.
$ 3000 (yes, no), urban residence (yes, no), parity (0, 1, >1), and folic acid
us), and diabetes mellitus (yes, no).
Table 3 Regression coefficient (95% CI)† of additive model
for blood pressure by categories of BMI and Hb levels
in pregnancy
Variable SBP DBP
β (95% CI) P value β (95% CI) P value
First trimester
Constant 70.3 (64.0, 76.6) <0.001 55.6 (47.9, 63.3) <0.001
bmi 2.6 (0.3, 4.9) 0.01 2.5 (0.1, 4.9) 0.03
hb 1.4 (−0.3, 3.1) 0.09 1.0 (−1.0, 3.0) 0.16
bmi × hb −1.1 (−3.7, 1.6) 0.14 0.4 (−2.3, 3.1) 0.38
Second trimester
Constant 72.1 (65.8, 78.4) <0.001 56.9 (49.1, 64.7) <0.001
bmi 1.9 (−0.5, 4.3) 0.22 0.8 (−1.5, 3.2) 0.32
hb 0.6 (−1.6, 2.8) 0.54 −0.2 (−2.3, 1.9) 0.63
bmi × hb 0.1 (−2.6, 2.8) 0.30 0.9 (−1.7, 3.5) 0.11
Third trimester
Constant 74.1 (67.8, 80.4) <0.001 59.3 (51.6, 67.0) <0.001
bmi 2.0 (0.3, 3.7) 0.009 2.2 (0.2, 4.2) 0.01
hb 0.8 (−1.1, 2.7) 0.27 1.2 (−1.0, 3.4) 0.12
bmi × hb 2.0 (0.1, 3.9) 0.02 2.3 (0.4, 4.3) 0.004
†Adjusted for age (continuous), ethnicity (Han, Zhuang, other), education
(<12 years, ≥12 years), family income < US$ 3000 (yes, no), urban residence
(yes, no), parity (0, 1, >1), folic acid supplement (yes, no), total cholesterol
(continuous), triglycerides (continuous), and diabetes mellitus (yes, no).
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tional adiposity with dyslipidaemia, hyperglycaemia, and
insulin resistance are well recognized [4,23-25]. These
risk patterns lead to oxidative stress and lipoprotein
oxidation contributing to endothelial dysfunction [26]
that is characterized by the pathogenesis of preeclampsia
[27]. Additionally, several functional changes associated
with maternal obesity, including lipid alternations, sleepTable 4 Difference (95% CI) in blood pressure by categories o
Non-high BMI (<28.5 kg/m2)
Hb <13.0 g/dL Hb ≥13.0
Number 2201 488
SBP (mmHg)a 106.3 107.7
Model 1b 0.0 (reference) 1.1 (−1.3,
Model 2c 0.0 (reference) 0.9 (−1.5,
Model 3d 0.0 (reference) 0.6 (−1.6,
DBP (mmHg)a 66.2 66.4
Model 1b 0.0 (reference) 0.5 (−1.9,
Model 2c 0.0 (reference) 0.2 (−2.0,
Model 3d 0.0 (reference) −0.2 (−2.3
CI, confidence interval; SBP, systolic blood pressure; DBP, diastolic blood pressure; H
aMean SBP; mean DBP.
bModel 1: Adjusted for age (continuous) and ethnicity (Han, Zhuang, other).
cModel 2: Further adjusted for education (<12 years, ≥12 years), family income < US
supplement (yes, no).
dModel 3: Further adjusted for total cholesterol (continuous), triglycerides (continuoapnea, and increased cardiac output and oxygen consump-
tion, are involved in hypertensive disorders in pregnancy
[28-30]. For Hb, the mechanisms that contribute to hyper-
tensive disorders of pregnancy may be related with blood
viscosity, which can be induced by elevation of hematocrit
and Hb levels, since it has been suggested that increased
blood viscosity may worsen cardiovascular function partly
through an effect on blood pressure [31]. Given this finding
regarding blood viscosity, it might probably explain the
previous studies [7-9] that the positive associations between
increased Hb and PIH were in agreement with elevated
blood viscosity during pregnancy. Furthermore, free Hb is a
scavenger of nitric oxide (NO), which can relax the muscle
cells, increased free Hb levels may thus bind to NO and
contribute to vasoconstriction and hypertension [32,33].
With so many potential mechanisms involved, perhaps it
is not surprised by the differences in the associations of
BMI and Hb concentrations with SBP or DBP throughout
pregnancy.
This is the first analysis to our knowledge of the
potential interaction between high BMI and high Hb
concentrations on blood pressure in pregnancy. Our
main finding is that both SBP and DBP are significantly
elevated in women with high BMI and high Hb in the
third trimester of pregnancy, and the interaction between
high BMI and high Hb indicates a synergistic effect on
blood pressure. In contrast to the second trimester, both
high BMI and high Hb were more likely to raise higher
blood pressure in the first and third trimesters, however,
further comparison with the first trimester, blood pressure
elevated by the individual effect of high BMI or high Hb
was consistent in the third trimester. Therefore, this
suggests that the interaction in the third trimester, may
not only depend on the excess amounts in blood pres-
sure raised by high levels of BMI and Hb, but also thef BMI and Hb levels in second trimester
High BMI (≥28.5 kg/m2)
g/dL Hb <13.0 g/dL Hb ≥13.0 g/dL
190 109
108.6 108.9
3.4) 2.2 (−0.6, 5.0) 3.2 (1.0, 5.5)
3.3) 2.1 (−0.4, 4.6) 3.0 (0.9, 5.1)
2.8) 1.9 (−0.5, 4.3) 2.6 (0.4, 4.8)
67.2 68.1
2.8) 1.4 (−1.0, 3.8) 2.2 (−0.8, 5.2)
2.5) 1.2 (−1.1, 3.7) 2.2 (−0.7, 5.1)
, 1.9) 0.8 (−1.5, 3.2) 1.5 (−1.3, 4.3)
b, Hemoglobin.
$ 3000 (yes, no), urban residence (yes, no), parity (0, 1, >1), and folic acid
us), and diabetes mellitus (yes, no).
Table 5 Difference (95% CI) in blood pressure by categories of BMI and Hb levels in third trimester
Non-high BMI (<30.9 kg/m2) High BMI (≥30.9 kg/m2)
Hb <13.0 g/dL Hb ≥13.0 g/dL Hb <13.0 g/dL Hb ≥13.0 g/dL
Number 1435 600 148 78
SBP (mmHg)a 111.3 112.5 113.6 116.9
Model 1b 0.0 (reference) 1.3 (−1.0, 3.7) 2.2 (0.3, 4.1) 5.8 (3.2, 8.4)
Model 2c 0.0 (reference) 1.2 (−1.0, 3.4) 2.2 (0.2, 4.1) 5.6 (3.1, 8.1)
Model 3d 0.0 (reference) 0.8 (−1.1, 2.7) 2.0 (0.3, 3.7) 4.8 (2.3, 7.4)
DBP (mmHg)a 72.5 74.0 74.8 78.5
Model 1b 0.0 (reference) 1.9 (−0.6, 4.3) 2.5 (0.4, 4.7) 6.5 (3.8, 9.1)
Model 2c 0.0 (reference) 1.7 (−0.5, 3.9) 2.4 (0.3, 4.5) 6.2 (3.6, 8.8)
Model 3d 0.0 (reference) 1.2 (−1.0, 3.4) 2.2 (0.2, 4.2) 5.7 (3.2, 8.3)
CI, confidence interval; SBP, systolic blood pressure; DBP, diastolic blood pressure; Hb, Hemoglobin.
aMean SBP; mean DBP.
bModel 1: Adjusted for age (continuous) and ethnicity (Han, Zhuang, other).
cModel 2: Further adjusted for education (<12 years, ≥12 years), family income < US$ 3000 (yes, no), urban residence (yes, no), parity (0, 1, >1), and folic acid
supplement (yes, no).
dModel 3: Further adjusted for total cholesterol (continuous), triglycerides (continuous), and diabetes mellitus (yes, no).
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lysis, even although the synergistic effects on SBP and
DBP increased only 2 mmHg and 2.3 mmHg, respectively,
perhaps we cannot rule out the possible adverse effects
on pregnancy outcomes. Randomized controlled trial data
have shown that lowering SBP of 3 mmHg may result
in a 16% reduction of cardiovascular events and a 22%
reduction of fatal and nonfatal strokes [34]. For pregnant
women, the biological effect of interaction on increased
blood pressure, even with small scale, thus needs to be
confirmed in further studies. Moreover, the tendency of
blood pressure in women with high BMI and high Hb
concentrations may need to be monitored with care
during the antenatal visit.
The mechanisms underlying the interaction between
high BMI and high Hb on increased blood pressure are
unclear. Based on the association of elevated blood viscosity
with adiposity or increased Hb levels [7,10-13], the present
study partly supports our hypothesis that high BMI and
high Hb may have a combined effect on increased blood
pressure via elevated blood viscosity during normal preg-
nancy. However, we do not have a good explanation on
mechanism for the interaction in the third trimester,
but not in the first and second trimesters. Generally in
normal pregnancy, blood volume, stroke volume, and
cardiac output increase progressively from the first
trimester until term [35], whereas blood viscosity has a
drop until 29 weeks gestation, followed by a small increase
toward term [36]. In our study, we cannot determine the
change in hemodynamics owing to lack of measuring
blood viscosity using viscometer, further studies thus
need to systematically evaluate the role of blood viscosity
in the associations of increased BMI and Hb concentra-
tions with blood pressure in pregnancy.The present study has some limitations. First, owing
to our cross-sectional analysis, we cannot determine the
causality between increased BMI or Hb concentrations
and elevated blood pressure. Second, the physiological
adaptations in maternal BMI, Hb concentrations, and
blood pressure are dynamic throughout pregnancy. We
cannot collect blood samples at every antenatal visit due
to the schedule in routine antenatal care, hence this
probably weakened the representation of 3 trimesters of
pregnancy only using the measurement at study entry,
around gestational weeks 20 and 24, 32 and 36. Third,
we accumulatively lost 943 (21%) and 417 (14%) partici-
pants with the follow-up in two subsequent trimesters,
respectively. Based on our analysis, the characteristics
of participants lost to follow up were not significantly
different with participants who remained in follow up
except for family income and urban residence. More-
over, the regression coefficients in each trimester did
not significantly change after adjustment for the two
variables, our results thus did not substantially be
influenced by loss to follow up.Conclusions
BMI and Hb concentrations appear to have different
associations with blood pressure throughout pregnancy.
Even more important, our findings indicate a synergistic
effect between high BMI and high Hb on blood pressure
in the third trimester of pregnancy. Further prospective
research is needed to identify the biological mechanism
of interaction, and evaluate its clinical role in pregnancy.Competing interests
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